Bolt Biotherapeutics, Inc. (BOLT)
$4.11+12.60%Close
BUYRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $8M
- Beta
- 1.01
- P/E (TTM)
- -0.22
- Short % float
- 1.64%
- Days to cover
- 1.0
- SI change
- +39.2%
- 1W
- +19.13%
- 1M
- +10.19%
- vs SPY 1W
- +17.97%
- vs SPY 1M
- +7.20%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BOLT?
- LOPJLB’s latest quantitative signal on Bolt Biotherapeutics, Inc. (BOLT) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is BOLT in?
- Bolt Biotherapeutics, Inc. (BOLT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Bolt Biotherapeutics, Inc. (BOLT) do?
- Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HE…